Medtech Insights

The Latin American EP mapping and ablation device market will experience strong growth as a result of favorable demographic trends, increasing ablation procedure volumes and the introduction of…

The biosurgical agent market in Latin America will observe modest growth through 2032, primarily driven by surgical procedure volume growth, increasing evidence of the clinical benefits of…

The European PACS, RIS, and CVIS market will continue to expand through 2032, despite the short-term negative impact of the COVID-19 pandemic, driven by Europe’s increasingly aging population,…

The US biopsy device market has shown strong recovery from the impacts of the COVID-19 pandemic and is anticipated to resume prepandemic growth trends in the near term, with subsequent slow growth…

The Latin American heart valve device market will be driven by expanding patient pool and availability of several new THV devices. Rapid adoption of these devices and positive results from…

Following the recovery from the impact of the COVID-19 pandemic, the US diagnostic imaging equipment servicing market will see marginal growth through 2032. The market growth will primarily be…

The Latin American CRM device market will be driven by the expanding patient pool and improving access to treatment in Latin American countries. The market will experience modest growth through…

The European market for breast implants and reconstruction devices will exhibit modest growth, driven by several key factors. The safety and aesthetic results of breast augmentation and…

Following the recovery from the impact of the COVID-19 pandemic, the European pain management device market will see moderate growth through 2032. Manufacturers in this space are actively…

The US minimally invasive spine technology market is characterized by modest procedure growth, fueled in large part by advancements to surgical techniques and enabling technologies which drive…

The biosurgical agent market in the US will observe modest growth through 2032, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical…

The biosurgical agent market in the US will observe modest growth through 2032, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical…